AI PhD Discovery Data Science Internship at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Currently enrolled in and attending school
PhD student with at least three years of completed graduate work in Statistics, Computer Science, Electrical and Computer Engineering, Operations Research, Mathematics/Applied Math, or closely related field

Responsibilities

Partner with research teams to identify, scope, and execute analytic efforts that answer scientific questions, solve business needs, and add business value
Maintain a broad understanding of drug discovery with scientific teams, bringing an objective voice to the table, and facilitating decisions grounded in data
Collaborate with other analytics team members to review and provide feedback on the analytics work being done, and be willing to seek feedback from other team members about your own work
Stay current with respect to statistical/mathematical/AI modeling methodology, to maintain proficiency in applying new and varied methods, and to be competent in justifying methods selected

Skills

Statistical Modeling

Machine Learning

Deep Learning

Natural Language Processing

Computer Vision

Image Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free